Tops & Flops Stocks
Security | Change (%) | 1w | 1m ▲ | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Arbutus Biopharma Corp. | -0.380% | -4.926% | 8.808% | 100.324% | 61.481% | 0.515% | 153.419% |
Fate Therapeutics Inc. | -2.770% | 3.171% | 9.116% | 62.313% | 0.647% | -94.135% | -76.657% |
Collegium Pharmaceutical Inc | - | 5.521% | 9.554% | 65.385% | 25.547% | 108.485% | 218.224% |
Abeona Therapeutics Inc. | -1.920% | 2.970% | 9.705% | 46.314% | 10.403% | -79.747% | -92.900% |
Amphastar Pharmaceuticals Inc | -1.270% | 9.658% | 9.926% | 3.819% | -20.619% | - | - |
Futura Medical | -0.480% | -1.429% | 10.695% | -25.405% | 52.206% | -16.532% | 23.214% |
Aurinia Pharmaceuticals Inc. | 0.780% | 8.519% | 10.832% | -19.626% | -20.908% | -63.959% | 15.272% |
Akero Therapeutics Inc | -0.840% | 3.832% | 11.332% | -49.673% | 13.119% | - | - |
Aldeyra Therapeutics Inc. | -2.950% | 0.632% | 11.463% | -10.405% | 66.749% | -25.808% | - |
Verastem Inc. | -0.790% | 0.800% | 11.504% | -72.757% | -66.623% | -91.094% | -82.723% |
Chromadex Corp | -4.240% | 4.430% | 12.245% | 150.000% | 150.000% | -37.143% | -12.733% |
ALK-Abelló A/S B | -1.480% | -0.164% | 12.442% | - | - | - | - |
Protalix Biotherapeutics Inc. | 3.700% | 4.431% | 12.837% | -40.806% | -41.562% | -19.193% | -48.851% |
Pacira Pharmaceuticals | 0.770% | 14.035% | 13.043% | -57.792% | -56.376% | -71.739% | -61.060% |
Virbac S.A. | 0.130% | 9.450% | 13.950% | 50.097% | 8.078% | 1.971% | 94.389% |
Ocuphire Pharma Inc. | 1.690% | 15.398% | 13.986% | -64.899% | -53.345% | -70.498% | - |
Cellectis Nom. | -5.280% | 0.240% | 14.059% | 31.380% | -28.054% | -83.090% | -80.766% |
Syros Pharmaceuticals Inc. | -3.930% | 26.241% | 14.103% | -50.693% | -73.030% | -95.880% | - |
Rhythm Pharmaceuticals | 2.480% | 9.375% | 15.023% | 104.167% | 15.023% | - | - |
Evolus Inc | 0.690% | 8.209% | 15.079% | 72.619% | 60.221% | 116.418% | - |
EyePoint Pharmaceuticals Inc. | -1.000% | 11.069% | 15.281% | -7.254% | -61.283% | -4.000% | -50.043% |
Gritstone Oncology Inc | -0.790% | 31.482% | 18.535% | -55.512% | -69.160% | -94.138% | -92.838% |
Corcept Therapeutics Inc. | 2.290% | 13.643% | 18.916% | 18.226% | 22.167% | 109.429% | 196.425% |
Medivir AB | -8.300% | 30.180% | 18.930% | -52.522% | 32.084% | -71.329% | -85.374% |
Mayne Pharma Group Ltd. | -1.440% | -2.797% | 19.828% | 36.275% | -26.064% | 1506.936% | 801.427% |